Back
65· Active
Technology1h 31m ago
Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy.
Baylor College of Medicine
Who
researchers at Baylor College of Medicine and collaborating institutions
What
Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy.
When
Fri, 17 Jul 2026 02:56:00 GMT · 1h 31m ago
Where
Baylor College of Medicine ·
Why
Researchers identified a vulnerability in these cells that can be used to their advantage.
The Frontline Impact
How this affects you
This discovery reveals a new treatment strategy for aggressive breast cancers that are resistant to chemotherapy.
Story chain
1 event in this threadNo related history yet - this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.